Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

American Journal of Pathology - United States
doi 10.2353/ajpath.2010.090875
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

15-Hydroxyprostaglandin Dehydrogenase (15-Pgdh) and Lung Cancer

Prostaglandins and Other Lipid Mediators
BiochemistryCell BiologyPharmacologyPhysiology
2007English

Loss of 15-Hydroxyprostaglandin Dehydrogenase Increases Prostaglandin E2 in Pancreatic Tumors

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2010English

Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2008English

Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer

Journal of Immunology
AllergyImmunology
2009English

Loss of P63 Expression Is Associated With Tumor Progression in Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2002English

A Potential Anti-Tumor Effect of Leukotriene C4 Through the Induction of 15-Hydroxyprostaglandin Dehydrogenase Expression in Colon Cancer Cells

Oncotarget
Oncology
2017English

A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression

Cancer Research
Cancer ResearchOncology
2009English

Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression

PLoS ONE
Multidisciplinary
2012English

Loss of SPARC in Bladder Cancer Enhances Carcinogenesis and Progression

Journal of Clinical Investigation
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy